24 The greater efficacy of semaglutide compared with liraglutide has been attributed to differences in pharmacokinetic and molecular properties, including enhanced albumin binding, prolonged half-life, and increased resistance to dipeptidyl peptidase-4 degradation
All randomised participants were included in the FAS, and all except for two participants in the oral semaglutide 7 mg arm and one participant in the sitagliptin 100 mg arm were exposed to the trial product and included in the SAS (Fig
These intricate networks function optimally when properly supported, yet gradually lose efficiency as we age
Table 1 includes the starting cervical segment for 8 cords
12 mg was the maximum tested in the Jastreboff et al
We excluded 1) those with diagnoses of AF, atrial tachycardia, ventricular tachycardia, ventricular fibrillation, mechanical valve, hyperthyroidism, or mitral stenosis before or on the index date, 2) those with cardiac events (i.e., myocardial infarction, percutaneous intervention, valve/bypass surgery) in the preceding 3 months, 3) those currently receiving antiarrhythmic medications (e.g., amiodarone, dronedarone, flecainide, propafenone, or dofetilide) on the index date, 4) those who used insulin within one year prior or on the index date, and 5) those who do not have hemoglobin A1C (HbA1c) within one year prior or on the index date (eFigure 1)
